Aurora Cannabis 以 4400 万美元收购 MedReleaf Australia 90% 的股份，以扩大澳大利亚 4 亿美元的医用大麻市场。 Aurora Cannabis acquires 90% of MedReleaf Australia for $44M to expand in Australia's $400M medical cannabis market.

加拿大大麻公司 Aurora Cannabis 以约 4400 万美元收购了澳大利亚医用大麻公司 MedReleaf Australia 90% 的股份。 Aurora Cannabis, a Canadian cannabis company, has acquired 90% of Australian medical cannabis company MedReleaf Australia for approximately $44 million. 此次收购旨在利用澳大利亚不断增长的医用大麻市场（目前估计为 4 亿澳元），加速 Aurora 实现正自由现金流的道路。 This acquisition is positioned to accelerate Aurora's path to positive free cash flow generation by leveraging Australia's growing medical cannabis market, which is now estimated at $400 million. Aurora 第三季度净亏损 2550 万加元，但仍致力于其战略扩张计划。 Aurora has experienced a third-quarter net loss of $25.5 million (CAD) but remains committed to its strategic expansion plan.